Status:
UNKNOWN
Enzyme Activity of Matrix Metalloproteinases in the Serum of Patients With Malignant Obstructive Hyperbilirubinemia Before and After PTBD
Lead Sponsor:
Institut za Rehabilitaciju Sokobanjska Beograd
Collaborating Sponsors:
Klinički centar Srbije
Conditions:
Matrix Metalloproteinase
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to detect differences in the enzymatic activity of matrix metalloproteinases in patients with malignant obstructive hyperbilirubinemia before and after percutaneous biliar...
Detailed Description
This study will be designed as a prospective cohort study involving the collection of peripheral blood samples before and one month after percutaneous biliary drainage for further molecular biochemica...
Eligibility Criteria
Inclusion
- pathological confirmation or imaging data confirming malignant disease causing bile duct obstruction, performance status 0-1
Exclusion
- terminally ill patients, performance status \>2, hepatic decompensation, severe underlying cardiac or renal diseases and coagulation disorders.
Key Trial Info
Start Date :
December 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 11 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04801914
Start Date
December 11 2020
End Date
May 11 2021
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinical Center of Serbia
Belgrade, Serbia, 11000